Beclomethasone Dipropionate
- 1 January 1975
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 10 (3) , 211-217
- https://doi.org/10.2165/00003495-197510030-00003
Abstract
At doses similar to those used in the treatment of chronic bronchial asthma, intranasal beclomethasone dipropionate is effective in alleviating nasal symptoms of seasonal allergic and perennial rhinitis in about three-quarters of patients. Eye symptoms are not relieved. The carry-over effect of the evening dose is useful in preventing early morning attacks of sneezing. Intranasal beclomethasone dipropionate is useful in controlling symptoms persisting after polypectomy and may possibly delay or eliminate the need for the surgical removal of nasal polyps, which may shrink after several weeks or months of treatment.Keywords
This publication has 8 references indexed in Scilit:
- Intranasal beclomethasone diproprionate in allergic rhinitis.BMJ, 1975
- Beclomethasone dipropionate in the treatment of nasal allergy in children.1975
- Intranasal beclomethasone dipropionate aerosol in allergic nasal diseases.1975
- Double-blind Cross-over Trial Comparing Intranasal Beclomethasone Dipropionate and Placebo in Perennial RhinitisBMJ, 1974
- The effect of intra‐nasal beclomethasone dipropionate on adrenal functionClinical and Experimental Allergy, 1974
- LOCAL EFFECT OF INTRANASAL BECLOMETHASONE DIPROPIONATE AEROSOL IN PERENNIAL RHINITISAllergy, 1974
- Local Effect of Intranasal Beclomethasone Dipropionate Aerosol in Hay FeverBMJ, 1973
- Value of Inhalation Tests in Bronchial AsthmaRespiration, 1969